A miniprotein scaffold used to assemble the polyproline II binding epitope recognized by SH3 domains.
暂无分享,去创建一个
L. Serrano | Jose C. Martínez | M. Pisabarro | E. Lacroix | M. C. Vega | J. Ruiz-Sanz | E. S. Cobos | M. Vega | Eva S. Cobos | Jose C. Martinez | M. Cristina Vega
[1] V. Filimonov,et al. Thermodynamic analysis of the unfolding and stability of the dimeric DNA-binding protein HU from the hyperthermophilic eubacterium Thermotoga maritima and its E34D mutant. , 2004, European journal of biochemistry.
[2] Irene Luque,et al. Thermodynamic dissection of the binding energetics of proline-rich peptides to the Abl-SH3 domain: implications for rational ligand design. , 2004, Journal of molecular biology.
[3] D. Mojzita,et al. The SH3 domain of Src can downregulate its kinase activity in the absence of the SH2 domain-pY527 interaction. , 2002, Biochemical and biophysical research communications.
[4] B. Seong,et al. A dipalmitoyl peptide that binds SH3 domain, disturbs intracellular signal transduction, and inhibits tumor growth in vivo. , 2002, Biochemical and biophysical research communications.
[5] R. Annan,et al. Identification of Novel SH3 Domain Ligands for the Src Family Kinase Hck , 2002, The Journal of Biological Chemistry.
[6] Sreenath V. Sharma,et al. UCS15A, a novel small molecule, SH3 domain-mediated protein–protein interaction blocking drug , 2002, Oncogene.
[7] M G Fried,et al. Host-guest study of left-handed polyproline II helix formation. , 2001, Biochemistry.
[8] R. A. Etten,et al. Mutational analysis of the regulatory function of the c-Abl Src homology 3 domain , 2001, Oncogene.
[9] M. Vidal,et al. SH2 and SH3 domains as targets for anti-proliferative agents. , 2001, Critical reviews in oncology/hematology.
[10] L. Serrano,et al. Computer-assisted re-design of spectrin SH3 residue clusters. , 2001, Biomolecular engineering.
[11] I. Campbell,et al. The Role of the Src Homology 3-Src Homology 2 Interface in the Regulation of Src Kinases* , 2001, The Journal of Biological Chemistry.
[12] Luis Serrano,et al. Computational estimation of specific side chain interaction energies in α helices , 2001 .
[13] B. Mayer,et al. SH3 domains: complexity in moderation. , 2001, Journal of cell science.
[14] A. Skerra. Engineered protein scaffolds for molecular recognition , 2000, Journal of molecular recognition : JMR.
[15] M. Sudol,et al. The importance of being proline: the interaction of proline‐rich motifs in signaling proteins with their cognate domains , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[16] Jie J. Zheng,et al. Rational Development of Cell‐Penetrating High Affinity SH3 Domain Binding Peptides That Selectively Disrupt the Signal Transduction of Crk Family Adapters , 1999, Annals of the New York Academy of Sciences.
[17] S. Pongor,et al. A thermodynamic study of the 434-repressor N-terminal domain and of its covalently linked dimers. , 1999, European journal of biochemistry.
[18] P. McPherson,et al. Regulatory role of SH3 domain-mediated protein-protein interactions in synaptic vesicle endocytosis. , 1999, Cellular signalling.
[19] F E Cohen,et al. Exploiting the basis of proline recognition by SH3 and WW domains: design of N-substituted inhibitors. , 1998, Science.
[20] T. Creamer. Left‐handed polyproline II helix formation is (very) locally driven , 1998, Proteins.
[21] L. Serrano,et al. Crystal structure of the abl-SH3 domain complexed with a designed high-affinity peptide ligand: implications for SH3-ligand interactions. , 1998, Journal of molecular biology.
[22] Z. Zhang,et al. Low-affinity binding determined by titration calorimetry using a high-affinity coupling ligand: a thermodynamic study of ligand binding to protein tyrosine phosphatase 1B. , 1998, Analytical biochemistry.
[23] G. Superti-Furga,et al. An intramolecular SH3-domain interaction regulates c-Abl activity , 1998, Nature Genetics.
[24] B. Calabretta,et al. The SH3 domain contributes to BCR/ABL-dependent leukemogenesis in vivo: role in adhesion, invasion, and homing. , 1998, Blood.
[25] Brian K. Kay,et al. Inhibition of Lyn function in mast cell activation by SH3 domain binding peptides. , 1997, Biochemistry.
[26] Scott A. Peterson,et al. Characterization of the WW Domain of Human Yes-associated Protein and Its Polyproline-containing Ligands* , 1997, The Journal of Biological Chemistry.
[27] P. Leder,et al. FBP WW domains and the Abl SH3 domain bind to a specific class of proline‐rich ligands , 1997, The EMBO journal.
[28] Michael J. Eck,et al. Three-dimensional structure of the tyrosine kinase c-Src , 1997, Nature.
[29] L Serrano,et al. Rational design of specific high-affinity peptide ligands for the Abl-SH3 domain. , 1996, Biochemistry.
[30] M. Sudol,et al. The WW domain of Yes-associated protein binds a proline-rich ligand that differs from the consensus established for Src homology 3-binding modules. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[31] Wendell A. Lim,et al. Structural determinants of peptide-binding orientation and of sequence specificity in SH3 domains , 1995, Nature.
[32] Tony Pawson,et al. Protein modules and signalling networks , 1995, Nature.
[33] S. Schreiber,et al. Two binding orientations for peptides to the Src SH3 domain: development of a general model for SH3-ligand interactions. , 1995, Science.
[34] R. Rickles,et al. Identification of Src, Fyn, Lyn, PI3K and Abl SH3 domain ligands using phage display libraries. , 1994, The EMBO journal.
[35] M. Wittekind,et al. Orientation of peptide fragments from Sos proteins bound to the N-terminal SH3 domain of Grb2 determined by NMR spectroscopy. , 1994, Biochemistry.
[36] A. Sparks,et al. Identification and characterization of Src SH3 ligands from phage-displayed random peptide libraries. , 1994, The Journal of biological chemistry.
[37] M. Jaye,et al. Identification of a Src SH3 domain binding motif by screening a random phage display library. , 1994, The Journal of biological chemistry.
[38] L Serrano,et al. Characterization of the interaction of natural proline-rich peptides with five different SH3 domains. , 1994, Biochemistry.
[39] Andrea Musacchio,et al. High-resolution crystal structures of tyrosine kinase SH3 domains complexed with proline-rich peptides , 1994, Nature Structural Biology.
[40] Hongtao Yu,et al. Structural basis for the binding of proline-rich peptides to SH3 domains , 1994, Cell.
[41] S. A. Johnston,et al. Release of proteins and peptides from fusion proteins using a recombinant plant virus proteinase. , 1994, Analytical biochemistry.
[42] E. Giralt,et al. CD of proline‐rich polypeptides: Application to the study of the repetitive domain of maize glutelin‐2 , 1993, Biopolymers.
[43] P Cicchetti,et al. Identification of a ten-amino acid proline-rich SH3 binding site. , 1993, Science.
[44] D. Baltimore,et al. Identification of a protein that binds to the SH3 region of Abl and is similar to Bcr and GAP-rho. , 1992, Science.
[45] T. Creighton,et al. Kinetic roles and conformational properties of the non-native two-disulphide intermediates in the refolding of bovine pancreatic trypsin inhibitor. , 1992, Journal of molecular biology.
[46] P. Privalov,et al. Heat capacity of proteins. I. Partial molar heat capacity of individual amino acid residues in aqueous solution: hydration effect. , 1990, Journal of molecular biology.
[47] P. V. von Hippel,et al. Calculation of protein extinction coefficients from amino acid sequence data. , 1989, Analytical biochemistry.
[48] J. Martin,et al. Molecular structure of mammalian neuropeptide Y: analysis by molecular cloning and computer-aided comparison with crystal structure of avian homologue. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[49] T. Blundell,et al. X-ray analysis (1. 4-A resolution) of avian pancreatic polypeptide: Small globular protein hormone. , 1981, Proceedings of the National Academy of Sciences of the United States of America.
[50] E. S. Pysh,et al. Vacuum ultraviolet circular dichroism of poly(L-proline) I and II. , 1975, Journal of the American Chemical Society.
[51] J. Schellman. Circular dichroism and optical rotation , 1975 .
[52] J. Horwitz,et al. Absorption and circular dichroism spectra of ribonuclease-S at 77 degrees K. , 1971, The Journal of biological chemistry.
[53] Ettinger Mj,et al. Optical activity of insulin. I. On the nature of the circular dichroism bands. , 1971 .
[54] R. Stein. SH2 and SH3 Domains , 1998 .
[55] D Cowburn,et al. Modular peptide recognition domains in eukaryotic signaling. , 1997, Annual review of biophysics and biomolecular structure.
[56] R. Rickles,et al. SH3 domains and drug design: ligands, structure, and biological function. , 1997, Biopolymers.
[57] S. B. Brown. An Introduction to spectroscopy for biochemists , 1980 .